Posts

Showing posts with the label stocks to sell

Portfolios of Jhunjhunwala, Kacholia, Kedia & top 6 investors bleed. Check stocks they bought & sold

Image
[hfe_template id='11223'] [ad_1] India’s marquee investors played a cautious hand in the March quarter, trimming sails amid market turbulence. The billionaire Jhunjhunwala family saw the value of their equity portfolio dip to Rs 57,594 crore at the end of FY25 from Rs 68,285 crore in just 3 months, even as they bought more of Titan, Canara Bank, and Federal Bank. Mukul Agrawal’s portfolio value slid to Rs 5,633 crore; he exited six stocks but added Onesource and Jagsonpal Pharma, according to data pulled from the records of primeinfobase.com. Anil Goel’s value softened to Rs 1,845 crore as he sweetened bets on sugar and picked up DCM Nouvelle. Ashish Kacholia (Rs 1,743 crore) exited Awfis but loaded up on Zaggle and Aeroflex. Vijay Kedia’s portfolio shrank to Rs 1,074 crore amid trims in Tejas and Precision. Dolly Khanna was the outlier as her holdings rose to Rs 498 crore, thanks to bold buys in SOM Distilleries and Prakash Industries. This information is based on share...

Stocks to buy or sell today: Tata Motors, Gravita among top 9 trading ideas for 19 December 2024

Image
[hfe_template id='11223'] [ad_1] The Indian market is likely to trade lower on Thursday, tracking weak global cues. India VIX, a gauge of market volatility, dipped marginally by 0.78% to 14.37, reflecting growing apprehension among traders. The derivatives market shows a bearish undertone, with aggressive call writing leading the session. The 24,500-strike call accumulated the highest open interest at 1.14 crore contracts, underscoring it as a formidable resistance level. Conversely, the 24,000-strike put holds 85.55 lakh contracts, signifying robust support. “Heavy call writing in the 24,200–24,500 range reinforces strong resistance, while diminishing put positions at lower levels indicate waning bullish sentiment,” said Dhupesh Dhameja, Derivatives Analyst at SAMCO Securities. “The put-call ratio (PCR) declined sharply to 0.37 from 0.48, highlighting a bearish tilt. However, the oversold PCR suggests that a temporary pullback cannot be ruled out. The 'max pain'...